Dr. Michael Christie


IP Qualifications

Registered Australian and New Zealand Patent Attorney
Registered Australian Trade Mark Attorney
Accredited Consultant Qualified Person (Plant Breeder's Rights)

Academic Qualifications

QualificationInstitutionYear of Completion
Master of Intellectual PropertyUniversity of Technology Sydney2016
Doctor of Philosophy (Biochemistry) University of Queensland2011
Graduate Certificate in Research Commercialisation University of Queensland2010
Bachelor of Biotechnology (Honours)University of Queensland2006

Postdoctoral Research Experience

PositionOrganisation/InstitutionDate of Tenure
Postdoctoral fellowMax Planck Institute for Developmental Biology (Tuebingen, Germany)2012-2014


Institute of Patent and Trade Mark Attorneys of AustraliaMember
Intellectual Property Society of Australia and New ZealandMember
Asian Patent Attorneys AssociationMember
International Association for the Protection of Intellectual Property (AIPPI)Pharma and Biotech Standing Committee

Selected Patent Cooperation Treaty (PCT) Specifications

PCT Publication NumberTitle of Application
WO2018/232467Adoptive T cell therapy 2
WO2019/113061Compositions and methods for modulating gene expression
WO2020/041835Compositions and processes for producing vitamin K
WO2020/106351Increasing gene expression
WO2020/186313Liposomes and uses thereof
WO2020/037376Compositions and methods for reducing bacterial aggregation
WO2020/163017DNA binding proteins and uses thereof

Selected Publications - Scientific

Scientific Publications
Brosnan, Mitter, Christie et al. (2007) “Nuclear gene silencing directs reception of long-distance mRNA silencing in Arabidopsis” Proc. Natl. Acad. Sci. USA 104(37): 14741-14746
Paungfoo-Lonhienne, Lonhienne, Rentsch, Robinson, Christie et al. (2008) “Plants can use protein as a nitrogen source without assistance from other organisms” Proc. Natl. Acad. Sci. USA 105(11): 4524-4529
Christie et al. (2011) “Intron splicing suppresses RNA silencing in Arabidopsis” 68: 159-167
Christie and Carroll (2011) “SERRATE is required for intron suppression of RNA silencing in Arabidopsis” Plant Sig. Behav. 6(12): 2035-2037
Christie et al. (2011) “RNA decay and RNA silencing in plants: competition or collaboration?” Front. Plant Sci. 2: 99
Karlsson, Christie et al. (2015) “KH domain protein RCF3 is a tissue-biased regulator of the plant miRNA biogenesis cofactor HYL1” Proc. Natl. Acad. Sci. USA 112(45): 14096-101
Christie, Lang et al. (2018) “A Role for the F-Box Protein HAWAIIAN SKIRT in Plant miRNA Function” Plant Phys. 176(1): 730-741
Lange, Ndecky, Gomez-Diaz, Pflieger, Butel, Zumsteg, Kuhn, Piermaria, Chicher, Christie et al. (2019) “RST2 and RIPR connect the cytosolic RNA exosome to the Ski complex in Arabidopsis” Nature Comm. 10: 3871
Experience and Technical Background

Experienced in the following areas of patent practice:

  • Strategic IP advice
  • Patent drafting
  • Patent prosecution
  • Patent opposition and litigation
  • Validity and infringement advice
  • Pharmaceutical patent term extensions
  • Plant breeder’s rights

Primary patent practice areas by technology:

  • Pharmaceuticals
  • Immunology
  • Genetics and genomics
  • Protein engineering
  • Vaccines
  • Plant biotechnology

Scientific/research background:

A. General technical areas:

  • Genetics and genomics
  • Biochemistry
  • Molecular biology

B. Honours research:

  • Examined long distance movement of RNA in organisms and developed a model for studying the systemic spread of gene silencing.
  • Developed a business plan for the commercialisation of genetically modified rootstocks.
  • Awarded University Medal for Academic Excellence in biotechnology.

C. PhD research:

  • Examined the role that intron splicing plays in regulating gene expression.
  • Developed a rational approach to transgene construct design.
  • Dean’s Award for Research Higher Degree Excellence.

D. Postdoctoral research:

  • Undertook two forward genetic screens to identify genes regulating miRNA biogenesis and activity.
  • High throughput gene mapping using short-read DNA sequencing.
  • Novel gene identification and characterization.

Would you like to join the Spruson & Ferguson team?

Work For Us

Contact our Expert Team

Contact Us